Gary Hattersley sold $2.7M of Nuvation Bio (NUVB)

Executed Nov 20 2025, disclosed Nov 24 2025, 4 days later.

Value, as filed

$2.7M

369,051 sh across 2 lots

Executed

Nov 20 2025

the trade date, as filed

Disclosed

Nov 24 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

GH Gary Hattersley CHIEF SCIENTIFIC OFFICER profile →

Gary Hattersley (CHIEF SCIENTIFIC OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Nuvation Bio Inc. (NUVB). The largest single filing was $2.7M of NUVB (369,051 sh across 2 lots, as filed), executed Nov 20 2025.

The name

NUVB Nuvation Bio Inc. NUVB · Healthcare · 18 filings in 24 months ticker →

Healthcare · Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Gary Hattersley in NUVB

NUVBSALE Nuvation Bio Inc. $709K
100,000 sh × $7.09
Exec Aug 19
Filed Aug 21 · 4:49 PM ET NUVBSALE Nuvation Bio Inc. $502K
100,000 sh × $5.02
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET